Publication Cover
Sequential Analysis
Design Methods and Applications
Volume 28, 2009 - Issue 1
33
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Discussion on “A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen

Pages 41-43 | Received 04 Jan 2008, Accepted 20 Jul 2008, Published online: 04 Feb 2009

REFERENCES

  • Inoue , L. Y. T. , Thall , P. F. , and Berry , D. A. ( 2002 ). Seamlessly Expanding a Randomized Phase II Trial to Phase III , Biometrics 58 : 823 – 831 .
  • Kelly , P. J. , Stallard , N. , and Todd , S. ( 2005 ). An Adaptive Group Sequential Design for Phase II/III Clinical Trials that Involve Treatment Selection , Journal of Biopharmaceutical Statistics 15 : 641 – 658 .
  • Schaid , D. J. , Ingle , J. N. , Wieand , S. , and Ahmann , D. L. ( 1988 ). A Design for Phase II Testing of Anticancer Agents Within a Phase III Clinical Trial , Controlled Clinical Trials 9 : 107 – 118 .
  • Schaid , D. J. , Wieand , H. S. , and Therneau , T. M. ( 1990 ). Optimal Two-Stage Screening Designs for Survival Comparisons , Biometrika 77 : 507 – 513 .
  • Simon , R. , Wittes , R. E. , and Ellenberg , S. S. ( 1985 ). Randomized Phase II Clinical Trials , Cancer Treatment Reports 69 : 1375 – 1381 .
  • Stallard , N. and Todd , S. ( 2003 ). Sequential Designs for Phase III Clinical Trials Incorporating Treatment Selection , Statistics in Medicine 22 : 689 – 703 .
  • Thall , P. F. ( 2008 ). A Review of Phase 2–3 Clinical Trial Designs , Lifetime Data Analysis 14 : 37 – 53 .
  • Thall , P. F. , Simon , R. , and Ellenberg , S. S. ( 1988 ). Two-Stage Selection and Testing Designs for Comparative Clinical Trials , Biometrika 75 : 303 – 310 .
  • Thall , P. F. , Lee , J. J. , Tseng , C.-H. , and Estey , E. H. ( 1999 ). Accrual Strategies for Phase I Trials with Delayed Patient Outcome , Statistics in Medicine 18 : 1155 – 1169 .
  • Todd , S. and Stallard , N. ( 2005 ). A New Clinical Trial Design Combining Phases II and III: Sequential Designs with Treatment Selection and a Change of Endpoint , Drug Information Journal 39 : 109 – 118 .
  • Recommended by Nitis Mukhopadhyay

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.